About the Conference
For almost three decades, pharmaceutical, medical device and, more recently, biotech compliance professionals have been meeting at the annual Sharing Conference™.
The Alliance recognizes our attendees have a real need to expand their knowledge and gain new perspectives on complying with the federal and state laws that effect their company’s commercial operations. Prescription Drug Marketing Act (PDMA), Drug Supply Chain Security Act (DSCSA), Patient Protection and Affordable Care Act (PPACA), Physician Sunshine Act, CMS Open Payments data submission, Sample Transparency Reporting and new federal and state compliance mandates that effect their day-to-day responsibilities.
SHARING CONFERENCE GOAL:
Education
review current compliance challenges as well as the anticipated expansion of new regulations
Sharing
in an atmosphere of collaboration and common goals, attendees from both industry and vendor segments meet to discuss their challenges, best practices, and solutions
Today the need for compliance education is more crucial than ever as the breadth and scope of the health care industry faces unprecedented challenges. With every successful advance in legislation, science and business come insights into unexpected roadblocks that beg for solutions.
The more we educate ourselves, the better prepared we are to stand up to the challenges of our organization’s mission: to secure a safe and effective drug supply for our nation.
TOPICS OF FOCUS
- 340B Drug Discounts
- Alternative Sampling
- Best Business Practices
- Business Ethics
- CMS Open Payments
- Corporate Integrity Agreements (CIAs)
- Counterfeit Drugs
- Credentialing
- Data Integrity
- Data Intelligence
- DEA Compliance
- DQSA & DSCSA
- Employee Misconduct
- Field Force Monitoring For Cause Audits
- Fraud & Abuse
- Fulfillment & Logistics
- Inspection Readiness
- Internal & External Investigations
- Monitoring & Auditing
- Off Label Promotion
- OIG Guidelines
- Operational Management
- Outsourcing Strategies
- Practitioner Validation
- Regulatory Gray Areas
- Risk Assessment Risk Mitigation
- Sample Accountability & Compliance
- SOPs
- Speaker Programs
- State Requirements Disclosure Reporting
- Training
- 340B Drug Discounts
- Alternative Sampling
- Best Business Practices
- Business Ethics
- CMS Open Payments
- Corporate Integrity Agreements (CIAs)
- Counterfeit Drugs
- Credentialing
- Data Integrity
- Data Intelligence
- DEA Compliance
- DQSA & DSCSA
- Employee Misconduct
- Field Force Monitoring
- For Cause Audits
- Fraud & Abuse
- Fulfillment & Logistics
- Inspection Readiness
- Internal & External Investigations
- Monitoring & Auditing
- Off Label Promotion
- OIG Guidelines
- Operational Management
- Outsourcing Strategies
- Practitioner Validation
- Regulatory Gray Areas
- Risk Assessment
- Risk Mitigation
- Sample Accountability & Compliance
- SOPs
- Speaker Programs
- State Requirements Disclosure Reporting
- Training
Want to Learn More?
Reach out to us today and join our email list to be the first hear about Conference updates and news.
This website protects personal information. Learn more:
To request more information or to ask a question: